{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:06:55Z","timestamp":1740136015104,"version":"3.37.3"},"reference-count":10,"publisher":"The Endocrine Society","issue":"11","funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["RO1AR045955"],"award-info":[{"award-number":["RO1AR045955"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,1]]},"DOI":"10.1210\/en.2018-00690","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T14:02:05Z","timestamp":1537452125000},"page":"3655-3656","source":"Crossref","is-referenced-by-count":0,"title":["Letter to the Editor: \u201cIncreased Circulating FGF23 Does Not Lead to Cardiac Hypertrophy in the Male Hyp Mouse Model of XLH\u201d"],"prefix":"10.1210","volume":"159","author":[{"given":"Xiaobin","family":"Han","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5082-7896","authenticated-orcid":false,"given":"L Darryl","family":"Quarles","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2018,9,20]]},"reference":[{"issue":"5","key":"2019041122190237900_bib1","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1210\/en.2018-00174","article-title":"Increased circulating FGF23 does not lead to cardiac hypertrophy in the male Hyp mouse model of XLH","volume":"159","author":"Liu","year":"2018","journal-title":"Endocrinology"},{"issue":"10","key":"2019041122190237900_bib2","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1210\/jc.2016-2215","article-title":"Fibroblast growth factor 23 and cause-specific mortality in the general population: the Northern Manhattan study","volume":"101","author":"Souma","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2019041122190237900_bib3","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"issue":"1","key":"2019041122190237900_bib4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1681\/ASN.2017040412","article-title":"Cardiovascular effects of renal distal tubule deletion of the FGF receptor 1 gene","volume":"29","author":"Han","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2019041122190237900_bib5","doi-asserted-by":"crossref","first-page":"12398","DOI":"10.1038\/s41598-018-30098-1","article-title":"Cardiovascular interactions between fibroblast growth factor-23 and angiotensin II","volume":"8","author":"Pi","year":"2018","journal-title":"Sci Rep"},{"issue":"6","key":"2019041122190237900_bib6","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/emmm.201303716","article-title":"FGF23 regulates renal sodium handling and blood pressure","volume":"6","author":"Andrukhova","year":"2014","journal-title":"EMBO Mol Med"},{"key":"2019041122190237900_bib7","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3389\/fimmu.2018.00408","article-title":"The gut microbiota regulates endocrine vitamin D metabolism through fibroblast growth factor 23","volume":"9","author":"Bora","year":"2018","journal-title":"Front Immunol"},{"issue":"6","key":"2019041122190237900_bib8","doi-asserted-by":"crossref","first-page":"E1636","DOI":"10.1152\/ajpendo.00396.2007","article-title":"Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice","volume":"293","author":"Liu","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"2019041122190237900_bib9","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1681\/ASN.2014040325","article-title":"Soluble Klotho protects against uremic cardiomyopathy independently of fibroblast growth factor 23 and phosphate","volume":"26","author":"Xie","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2019041122190237900_bib10","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","article-title":"Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy","volume":"22","author":"Grabner","year":"2015","journal-title":"Cell Metab"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/159\/11\/3655\/26120737\/en.2018-00690.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T09:37:07Z","timestamp":1571909827000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/159\/11\/3655\/5103299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,20]]},"references-count":10,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,9,20]]},"published-print":{"date-parts":[[2018,11,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2018-00690","relation":{},"ISSN":["1945-7170"],"issn-type":[{"type":"electronic","value":"1945-7170"}],"subject":[],"published-other":{"date-parts":[[2018,11]]},"published":{"date-parts":[[2018,9,20]]}}}